Product Information
MEMANTINE HCL ER 7 MG CAPSULE is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.3449 per EA under NDC 69680016130. Its NADAC has been published 75 times since Mar 19, 2025.
FDA first approved this application on Oct 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680016130
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213985FDA Approved
10/11/2022
TE Code
AB
On Market Since
12/15/2023
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL ER 7 MG CAPSULE has been published 75 times since Mar 19, 2025, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3449 per EA |
|---|---|
| All-time high | $0.4586 (Oct 15, 2025) |
| All-time low | $0.2946 (May 20, 2026) |
| 52-week high | $0.4586 |
| 52-week low | $0.2946 |
| Median price | $0.3936 |
| Average price | $0.3801 |
| Largest weekly change | -11.0% (Feb 18, 2026) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEMANTINE HCL ER 7 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL ER 7 MG CAPSULE, manufactured by Vitruvias Therapeutics Inc., is $0.3449 per EA (NDC 69680016130), effective Aug 19, 2026.
How has the price of MEMANTINE HCL ER 7 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL ER 7 MG CAPSULE has declined 21.7%. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL ER 7 MG CAPSULE?
Since Mar 19, 2025, the NADAC for MEMANTINE HCL ER 7 MG CAPSULE has ranged from a low of $0.2946 (May 20, 2026) to a high of $0.4586 (Oct 15, 2025), with a median of $0.3936 per EA.
Are there cheaper alternatives to MEMANTINE HCL ER 7 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL ER 7 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEMANTINE HCL ER 7 MG CAPSULE?
MEMANTINE HCL ER 7 MG CAPSULE (NDC 69680016130) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.